The much anticipated results of a phase 2 clinical trial of exenatide have been published in The Lancet, and have since appeared widely in the media. The findings offer hope that drugs like exenatide can slow the course of Parkinson’s — something no current treatment can do. So, generally how does exenatide work?
byettahcp.com/science-of-by...
What is Glucagon-like peptide 1?
Glucagon-like peptide 1 is a hormone produced in the gut and released in response to food. It causes reduced appetite and the release of insulin.
Interesting. So this is a diabetes drug. But then instead of this you could just go low carb or Keto. I also think Mannitol slows progression. As might B1. As does exercise.